Department of Biomedical Sciences, University of Cagliari, 09042 Monserrato, Cagliari, Italy.
Int J Mol Sci. 2017 Nov 3;18(11):2322. doi: 10.3390/ijms18112322.
This review summarized different studies reporting the presence of autoantibodies reacting against cells of the pituitary (APAs) and/or hypothalamus (AHAs). Both APAs and AHAs have been revealed through immunofluorescence using different kinds of substrates. Autoantibodies against gonadotropic cells were mainly found in patients affected by cryptorchidism and hypogonadotropic hypogonadism while those against prolactin cells were found in different kinds of patients, the majority without pituitary abnormalities. APAs to growth hormone (GH) cells have been associated with GH deficiency while those against the adrenocorticotropic cells have distinguished central Cushing's disease patients at risk of incomplete cure after surgical adenoma removal. AHAs to vasopressin cells have identified patients at risk of developing diabetes insipidus. APAs have been also found together with AHAs in patients affected by idiopathic hypopituitarism, but both were also present in different kinds of patients without abnormalities of the hypothalamic-pituitary axis. Despite some data being promising, the clinical use of pituitary and hypothalamus autoantibodies is still limited by the low diagnostic sensitivity, irreproducibility of the results, and the absence of autoantigen/s able to discriminate the autoimmune reaction involving the pituitary or the hypothalamus from the other autoimmune states.
本文综述了不同研究中报道的针对垂体(APAs)和/或下丘脑(AHAs)细胞的自身抗体的存在情况。APAs 和 AHAs 均通过使用不同底物的免疫荧光法揭示。针对促性腺细胞的自身抗体主要在隐睾和促性腺激素低下性性腺功能减退症患者中发现,而针对催乳素细胞的自身抗体则在不同类型的患者中发现,其中大多数患者无垂体异常。针对生长激素(GH)细胞的自身抗体与 GH 缺乏有关,而针对促肾上腺皮质激素细胞的自身抗体则区分了中枢性库欣病患者,这些患者在腺瘤切除术后有不完全治愈的风险。针对血管加压素细胞的 AHAs 可识别出发生尿崩症的风险患者。自身抗体也在特发性垂体功能减退症患者中与 AHAs 一起发现,但在无下丘脑-垂体轴异常的不同类型患者中也存在自身抗体。尽管一些数据有希望,但垂体和下丘脑自身抗体的临床应用仍受到诊断灵敏度低、结果不可重现以及缺乏能够区分涉及垂体或下丘脑的自身免疫反应与其他自身免疫状态的自身抗原/抗体的限制。